These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 36147464)

  • 1. Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.
    Meng Y; Sun H; Li Y; Zhao S; Su J; Zeng F; Deng G; Chen X
    Int J Biol Sci; 2022; 18(14):5475-5488. PubMed ID: 36147464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.
    Lu L; Jifu C; Xia J; Wang J
    Biomed Pharmacother; 2024 Jun; 175():116753. PubMed ID: 38761423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of T helper cell differentiation by E3 ubiquitin ligases and deubiquitinating enzymes.
    Gao SF; Zhong B; Lin D
    Int Immunopharmacol; 2017 Jan; 42():150-156. PubMed ID: 27914308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitinase ZRANB1 is an E3 ubiquitin ligase for SLC7A11 and regulates ferroptotic resistance.
    Huang S; Zhang Q; Zhao M; Wang X; Zhang Y; Gan B; Zhang P
    J Cell Biol; 2023 Nov; 222(11):. PubMed ID: 37831441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinases in cancer.
    Dewson G; Eichhorn PJA; Komander D
    Nat Rev Cancer; 2023 Dec; 23(12):842-862. PubMed ID: 37935888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUBs, Hypoxia, and Cancer.
    Mennerich D; Kubaichuk K; Kietzmann T
    Trends Cancer; 2019 Oct; 5(10):632-653. PubMed ID: 31706510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme reversal to explore the function of yeast E3 ubiquitin-ligases.
    MacDonald C; Winistorfer S; Pope RM; Wright ME; Piper RC
    Traffic; 2017 Jul; 18(7):465-484. PubMed ID: 28382714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinases: Modulators of Different Types of Regulated Cell Death.
    Lee CS; Kim S; Hwang G; Song J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.
    Kubaichuk K; Kietzmann T
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ubiquitination and deubiquitination in tumor invasion and metastasis.
    Han S; Wang R; Zhang Y; Li X; Gan Y; Gao F; Rong P; Wang W; Li W
    Int J Biol Sci; 2022; 18(6):2292-2303. PubMed ID: 35414786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics.
    Lill JR; Wertz IE
    Trends Pharmacol Sci; 2014 Apr; 35(4):187-207. PubMed ID: 24717260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.
    Liu F; Chen J; Li K; Li H; Zhu Y; Zhai Y; Lu B; Fan Y; Liu Z; Chen X; Jia X; Dong Z; Liu K
    Mol Cancer; 2024 Jul; 23(1):148. PubMed ID: 39048965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response.
    Cammann C; Israel N; Slevogt H; Seifert U
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitylating enzymes: potential target in autoimmune diseases.
    Parihar N; Bhatt LK
    Inflammopharmacology; 2021 Dec; 29(6):1683-1699. PubMed ID: 34792672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression.
    Zheng C; Chen J; Wu Y; Wang X; Lin Y; Shu L; Liu W; Wang P
    Front Immunol; 2023; 14():1217466. PubMed ID: 37359559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HECT-Type E3 Ubiquitin Ligases in Cancer.
    Bernassola F; Chillemi G; Melino G
    Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of ubiquitination activity and identification of ubiquitinated substrates using TR-TUBE.
    Yoshida Y; Saeki Y; Tsuchiya H; Tanaka K
    Methods Enzymol; 2019; 618():135-147. PubMed ID: 30850049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases.
    Estavoyer B; Messmer C; Echbicheb M; Rudd CE; Milot E; Affar EB
    J Biol Chem; 2022 Aug; 298(8):102198. PubMed ID: 35764170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.